129 related articles for article (PubMed ID: 32268770)
1. Serum level of fibroblast growth factor 21 predicts long-term prognosis in patients with both diabetes mellitus and coronary artery calcification.
Gan F; Huang J; Dai T; Li M; Liu J
Ann Palliat Med; 2020 Mar; 9(2):368-374. PubMed ID: 32268770
[TBL] [Abstract][Full Text] [Related]
2. FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients.
Ozkok A; Kekik C; Karahan GE; Sakaci T; Ozel A; Unsal A; Yildiz A
BMC Nephrol; 2013 Nov; 14():241. PubMed ID: 24180481
[TBL] [Abstract][Full Text] [Related]
3. FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.
Turan MN; Kircelli F; Yaprak M; Sisman AR; Gungor O; Bayraktaroglu S; Ozkahya M; Asci G; Floege J; Ok E
Int Urol Nephrol; 2016 Apr; 48(4):609-17. PubMed ID: 26865177
[TBL] [Abstract][Full Text] [Related]
4. Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in patients with diabetes mellitus with coronary artery disease.
Tuñón J; Fernández-Fernández B; Carda R; Pello AM; Cristóbal C; Tarín N; Aceña Á; González-Casaus ML; Huelmos A; Alonso J; Lorenzo Ó; González-Parra E; Hernández-González I; Mahíllo-Fernández I; López-Bescós L; Egido J
Diabetes Metab Res Rev; 2016 Oct; 32(7):685-693. PubMed ID: 26888181
[TBL] [Abstract][Full Text] [Related]
5. FGF-23 and the progression of coronary arterial calcification in patients new to dialysis.
Khan AM; Chirinos JA; Litt H; Yang W; Rosas SE
Clin J Am Soc Nephrol; 2012 Dec; 7(12):2017-22. PubMed ID: 22997345
[TBL] [Abstract][Full Text] [Related]
6. Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.
Roos M; Lutz J; Salmhofer H; Luppa P; Knauss A; Braun S; Martinof S; Schömig A; Heemann U; Kastrati A; Hausleiter J
Clin Endocrinol (Oxf); 2008 Apr; 68(4):660-5. PubMed ID: 17970775
[TBL] [Abstract][Full Text] [Related]
7. Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease.
Unsal A; Kose Budak S; Koc Y; Basturk T; Sakaci T; Ahbap E; Sinangil A
Kidney Blood Press Res; 2012; 36(1):55-64. PubMed ID: 22854270
[TBL] [Abstract][Full Text] [Related]
8. Coronary artery calcification in patients with diabetes mellitus and advanced chronic kidney disease.
Cano-Megías M; Bouarich H; Guisado-Vasco P; Pérez Fernández M; de Arriba-de la Fuente G; Álvarez-Sanz C; Rodríguez-Puyol D
Endocrinol Diabetes Nutr (Engl Ed); 2019 May; 66(5):297-304. PubMed ID: 30509882
[TBL] [Abstract][Full Text] [Related]
9. High fibroblast growth factor 23 is associated with coronary calcification in patients with high adiponectin: analysis from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease (KNOW-CKD) study.
Hyun YY; Kim H; Oh YK; Oh KH; Ahn C; Sung SA; Choi KH; Kim SW; Lee KB
Nephrol Dial Transplant; 2019 Jan; 34(1):123-129. PubMed ID: 29701806
[TBL] [Abstract][Full Text] [Related]
10. Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.
Wong YK; Cheung CYY; Tang CS; Au KW; Hai JSH; Lee CH; Lau KK; Cheung BMY; Sham PC; Xu A; Lam KSL; Tse HF
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2519-2527. PubMed ID: 30354221
[TBL] [Abstract][Full Text] [Related]
11. [MORPHOGENETIC PROTEINS--FIBROBLAST GROWTH FACTOR AND KLOTHO, IN THE SERA OF PATIENTS WITH CHRONIC RENAL DISEASE].
Milovanova LY; Kozlovskaya LV; Markina MM; Milovanova SY; Borisov AA; Mukhin NA; Fomin VV; Moiseev SV
Klin Med (Mosk); 2015; 93(12):32-8. PubMed ID: 27149811
[TBL] [Abstract][Full Text] [Related]
12. Coronary calcification as a predictor of cardiovascular mortality in advanced chronic kidney disease: a prospective long-term follow-up study.
Cano-Megías M; Guisado-Vasco P; Bouarich H; de Arriba-de la Fuente G; de Sequera-Ortiz P; Álvarez-Sanz C; Rodríguez-Puyol D
BMC Nephrol; 2019 May; 20(1):188. PubMed ID: 31138150
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: the Cardiovascular Health Study.
Deo R; Katz R; de Boer IH; Sotoodehnia N; Kestenbaum B; Mukamal KJ; Chonchol M; Sarnak MJ; Siscovick D; Shlipak MG; Ix JH
Am J Kidney Dis; 2015 Jul; 66(1):40-6. PubMed ID: 25572028
[TBL] [Abstract][Full Text] [Related]
14. Plasma FGF23 and Calcified Atherosclerotic Plaque in African Americans with Type 2 Diabetes Mellitus.
Freedman BI; Divers J; Russell GB; Palmer ND; Bowden DW; Carr JJ; Wagenknecht LE; Hightower RC; Xu J; Smith SC; Langefeld CD; Hruska KA; Register TC
Am J Nephrol; 2015; 42(6):391-401. PubMed ID: 26693712
[TBL] [Abstract][Full Text] [Related]
15. Effect of serum FGF-23, MGP and fetuin-A on calcium-phosphate metabolism in maintenance hemodialysis patients.
Xiao DM; Wu Q; Fan WF; Ye XW; Niu JY; Gu Y
Hemodial Int; 2013 Oct; 17(4):483-92. PubMed ID: 23490272
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of low vitamin D and high fibroblast growth factor-23 plasma levels predicts an adverse outcome in patients with coronary artery disease.
Tuñón J; Cristóbal C; Tarín N; Aceña Á; González-Casaus ML; Huelmos A; Alonso J; Lorenzo Ó; González-Parra E; Mahíllo-Fernández I; Pello AM; Carda R; Farré J; Rodríguez-Artalejo F; López-Bescós L; Egido J
PLoS One; 2014; 9(4):e95402. PubMed ID: 24748388
[TBL] [Abstract][Full Text] [Related]
17. Serum S100A12 and Progression of Coronary Artery Calcification Over 4 Years in Hemodialysis Patients.
Wang YN; Sun Y; Wang Y; Jia YL
Am J Nephrol; 2015; 42(1):4-13. PubMed ID: 26278922
[TBL] [Abstract][Full Text] [Related]
18. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast growth factor-23 and cardiovascular events in CKD.
Scialla JJ; Xie H; Rahman M; Anderson AH; Isakova T; Ojo A; Zhang X; Nessel L; Hamano T; Grunwald JE; Raj DS; Yang W; He J; Lash JP; Go AS; Kusek JW; Feldman H; Wolf M;
J Am Soc Nephrol; 2014 Feb; 25(2):349-60. PubMed ID: 24158986
[TBL] [Abstract][Full Text] [Related]
20. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
Muras K; Masajtis-Zagajewska A; Nowicki M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
